Adaptive Multiple Comparison Sequential Design (AMCSD) for clinical trials

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Drug Development

Background:

• Evaluating multiple treatment options (e.g., doses, drugs, subpopulations) in a single clinical trial is complex.
• Traditional trial designs may lack flexibility in adapting to accumulating evidence.
• Efficiently assessing multiple hypotheses while maintaining statistical rigor is a challenge.

Purpose of the Study:

• To propose an adaptive sequential testing procedure for clinical trials.
• To enable simultaneous evaluation of multiple treatment options within one trial.
• To provide robust statistical inference after trial completion.

Main Methods:

• An adaptive sequential testing framework is developed.
• The procedure allows for interim analyses with sample size re-estimation.
• Options can be sequentially dropped based on efficacy or safety data.
• Post-trial inference includes p-values, point estimates, and confidence intervals.

Main Results:

• The proposed method allows for dynamic adjustments to sample size during the trial.
• Ineffective or unsafe treatment options can be identified and removed early.
• The procedure ensures valid statistical inference is maintained throughout the adaptive process.

Conclusions:

• The adaptive sequential testing procedure offers a flexible and efficient approach for multi-option clinical trials.
• This methodology enhances the ability to identify optimal treatments while managing resources effectively.
• The approach provides reliable statistical evidence for decision-making in drug development.